- Abstract Number: 2970
Vaccination Knowledge, Attitudes, and Uptake Among Patients with Rheumatic Diseases Across Arabian Gulf Countries
- Abstract Number: 1886
Vaccine Effectiveness and Safety of Recombinant Zoster Vaccine in Psoriatic Arthritis Patients Aged 18 Years and Older
- Abstract Number: 2538
Vaccine Uptake and Attitudes Toward Adult Vaccination Among Patients with Autoimmune Inflammatory Rheumatic Diseases Receiving Biologic Therapy With or Without Conventional Synthetic DMARDs in Bahrain: A Cross-Sectional Study
- Abstract Number: 1426
Vagus-Mediated Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis: Long-Term Results at 24 Months from a Randomized, Sham-Controlled, Double-Blind Trial
- Abstract Number: 1364
Validation of a Disease Activity Index for PSoriatic Arthritis Based on 44 Joints (DAPSA44) Using Data from Phase 3 Clinical Trials of Bimekizumab in Psoriatic Arthritis
- Abstract Number: 2191
Validation of anti-C1q, anti-dsDNA, and anti-Sm antibodies as reliable biomarkers for identifying lupus nephritis using a large real-world cohort of 62,734 patients
- Abstract Number: 1916
Validation of Cutaneous Lupus Erythematosus Disease Area and Severity Index-Activity (CLASI-A) for Evaluation of Patients with Cutaneous Lupus Erythematosus in Clinical Trials
- Abstract Number: 2151
Validation of Glucocorticoid Toxicities Experienced During Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Simulation Modeling Approach
- Abstract Number: 2380
Validation of ICD Diagnosis-Based and Large Language Model-Based Approaches to Identify Patients With Moderate to Severe Sjögren’s Disease
- Abstract Number: 0644
Validation of Markerless Motion Capture to Assess Physical Function in Knee Osteoarthritis
- Abstract Number: 2808
Validation of New Clinical Thresholds for Low Inflammatory Activity using Modified Disease Activity Scores in Rheumatoid Arthritis
- Abstract Number: 1013
Validation of Serum Cytokines During Pregnancy In Systemic Lupus Erythematosus
- Abstract Number: 1365
Validation of the Disease Activity Index for Psoriatic Arthritis Based on 44 Joints (DAPSA44) in Axial and Peripheral Spondyloarthritis: Evidence from 3 Randomised Controlled Trials
- Abstract Number: 1811
Validity of Fitbit Inspire 2 Activity Metrics in Adults after Knee Replacement
- Abstract Number: 0668
Validity of Functional Tests as Outcome Measures in Idiopathic Inflammatory Myopathies: Functional Index-3 (FI-3), Sit-to-Stand Test in 30 seconds (STS), and Timed Up and Go (TUG)
- Abstract Number: 1396
Variation in Pulmonary Complications amongst Primary Sjögren’s Syndrome Patients with Distinct Serological Profiles
- Abstract Number: 0191
Vascular Complications and Clinical Outcomes in Giant Cell Arteritis Patients with Indeterminate Temporal Artery Biopsy Results
- Abstract Number: 0090
Vascular Inflammation Drives Synovial Fibroblast Expansion and Remodelling In Rheumatoid Arthritis
- Abstract Number: 0091
Vascularized Synovium-on-a-Chip – a Patient-Derived Rheumatoid Arthritis Model that Mimics Disease, Biological Heterogeneity, and Actual Treatment Response
- Abstract Number: 1171
Vasculitis Relapse in Patients with Eosinophilic Granulomatosis with Polyangiitis. Prospective Data from a Clinical Trial
- Abstract Number: 0056
VE-cadherin: a potential marker of ongoing glomerular endothelial injury and future target in lupus nephritis
- Abstract Number: 2905
VERANDA™-SSc: Design of a Phase III, Double-blind, Randomized, Placebo-controlled Trial Evaluating the Safety and Efficacy of Oral Nerandomilast Treatment on Halting Disease Progression in Systemic Sclerosis
- Abstract Number: 0704
VEXAS Syndrome Identified in a Tertiary Rheumatology Center: A Case Series
- Abstract Number: 1085
Vimentin Modified with Malondialdehyde-Acetaldehyde Increases Lung Collagen Levels following Injection in DBA/1J Mice
- Abstract Number: 0127
Viral Remodeling of the MHC Class II Immunopeptidome Exposes SLE-Associated Autoantigens
- Abstract Number: 0798
Virtual rheumatology visits are associated with decreased odds of treatment changes for rheumatoid arthritis patients: a retrospective cohort study
- Abstract Number: 0439
Vitamin A deficiency in primary Sjögren’s disease
- Abstract Number: 0287
Voclosporin vs. Belimumab in Lupus Nephritis: Two-Year Renal Outcomes in a Retrospective Propensity Score-Matched Real-World Cohort
ACR Convergence 2026
November 6-11, 2026. Orlando, Florida.
